Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.230
-0.070 (-5.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $230.34 million as of December 5, 2025. Its market cap has decreased by -59.50% in one year.
Market Cap
230.34M
Enterprise Value
261.83M
1-Year Change
-59.50%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $230.34M, an increase of 85.30%. That is a compound annual growth rate of 13.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 230.34M | -64.55% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |